Table 1.
A brief summary and comparison of three highly pathogenic human coronaviruses (severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and coronavirus disease 2019 (COVID-19)) on the basis of their phylogenetic origin, basic demographic information, and associated events
Pandemics | SARS-CoV | MERS-CoV | COVID-19 | References |
---|---|---|---|---|
Place of origin | Foshan, Guangdong, China | Saudi Arabia | Wuhan, Hubei, Province, China | (da Costa et al. 2020) |
Date of emergence | Nov 2002 | June 2012 | December 2019 | (da Costa et al. 2020) |
Entry receptor in human | Angiotensin-converting enzyme 2 (ACE-2) | Dipeptidyl peptidase-4 (DPP4) | (ACE-2) | (Lu et al. 2020) (Wang et al. 2008) (Li et al. 2020) |
Mode of transmission | Droplet contacts with the infected individual | Respiratory droplets, contaminated fomites | Droplet contact with an infected individual (even if asymptotic one), aerosol transmission, blood-borne transmission, child-mother, and sexual transmission contaminated fomites, oral-fecal | (Shashank et al. 2021, Karia et al. 2020) |
Incubation period | 4 days (~ 1–13 days) | 5 days (~ 2–15 days) | 5 days (2–14 days) | – |
Countries and territories affected | 29 | 27 | 268 | (Al-Qahtani 2020) |
Current status | Completely controlled | – | Ongoing pandemic | – |
Fatality ratio | 9.5% | 34.4% | 4.4% | (Petrosillo et al. 2020) |